Enalapril maleate and Lysodren drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Enalapril maleate and Lysodren. Common interactions include adrenal insufficiency among females.

The phase IV clinical study analyzes what interactions people who take Enalapril maleate and Lysodren have. It is created by eHealthMe based on reports of 7 people who take Enalapril maleate and Lysodren from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

7 people who take Enalapril maleate and Lysodren together, and have interactions are studied.


What is Enalapril maleate?

Enalapril maleate has active ingredients of enalapril maleate. It is often used in high blood pressure. eHealthMe is studying from 32,007 Enalapril maleate users for its effectiveness, alternative drugs and more.

What is Lysodren?

Lysodren has active ingredients of mitotane. eHealthMe is studying from 750 Lysodren users for its effectiveness, alternative drugs and more.

Number of Enalapril maleate and Lysodren reports submitted per year:

Enalapril maleate and Lysodren drug interactions.

Common Enalapril Maleate and Lysodren drug interactions by gender *:

female:

  1. Adrenal insufficiency
  2. Anaemia
  3. Malignant neoplasm progression
  4. Renal failure
  5. Adrenal carcinoma
  6. Adrenocortical carcinoma
  7. Adrenal neoplasm
  8. Drug ineffective
  9. Hyperkalaemia
  10. Shock haemorrhagic

male:

n/a

Common Enalapril Maleate and Lysodren drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Adrenal insufficiency
  2. Anaemia
  3. Malignant neoplasm progression
  4. Renal failure
  5. Adrenal carcinoma
  6. Adrenocortical carcinoma
  7. Adrenal neoplasm
  8. Drug ineffective
  9. Hyperkalaemia
  10. Shock haemorrhagic

* Approximation only. Some reports may have incomplete information.

Do you take Enalapril maleate and Lysodren?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Enalapril maleate and Lysodren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Enalapril maleate side effects:

Browse all side effects of Enalapril maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lysodren side effects:

Browse all side effects of Lysodren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Enalapril maleate interactions:

Browse all interactions between Enalapril maleate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lysodren interactions:

Browse all interactions between Lysodren and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on enalapril maleate and mitotane (the active ingredients of Enalapril maleate and Lysodren, respectively), and Enalapril maleate and Lysodren (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Enalapril maleate and Lysodren.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: